Colo-rectal Cancer
Oncology·MeSH: Colonic Neoplasms
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
3 drugs in development·1 company·12 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Panitumumbab | IGM Biosciences, Inc. (IGMS) |
Early Phase 1(1)
Phase 4(1)
| Drug | Company |
|---|---|
| Leucovorin | IGM Biosciences, Inc. (IGMS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Colo-rectal Cancer?
BioSniper tracks 3 drugs in development for Colo-rectal Cancer across 1 company.
How many clinical trials target Colo-rectal Cancer?
There are 12 clinical trials targeting Colo-rectal Cancer tracked by BioSniper.
What is the prevalence of Colo-rectal Cancer?
The estimated prevalence of Colo-rectal Cancer is approximately 135.0 per 100,000 population.
Deep-dive into Colo-rectal Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis